We are pleased to announce that the acquisition of Avid Bioservices by GHO Capital Partners and Ampersand Capital Partners has been completed. Read the Press Release

Facilities

State-of-the-art facilities powering your program's success.

We provide our clients flexibility by offering endless options and work with you to align timelines.

Mammalian Protein and Viral Vector Sites

We are known for our state-of-the-art CDMO campuses and purpose-built facilities designed to support both mammalian protein and viral vector manufacturing needs. Our facilities feature advanced single-use bioreactors and flexible CGMP suites tailored for efficient and scalable production of biologics. We provide end-to-end solutions with an unwavering commitment to quality and personalized care.

Mammalian Protein Process Development & CGMP Manufacturing

Tustin, California

Avid’s mammalian protein CDMO facilities span 160,000 ft2, with more than 575 batches produced. Equipped with state-of-the-art single-use design, the facility offers more than 20,000L SUB capacity, ensuring scalability and efficiency for biologics manufacturing.

Viral Vector Process Development and CGMP Manufacturing

Costa Mesa, California

Our 53,000 ft2 viral vector CDMO site offers advanced process development labs, CGMP production trains, 6,000 ft2 of on-site QC labs, and fill-finish capabilities for end-to-end gene therapy solutions.

Discover the Avid effect.â„¢

Find out how Avid Bioservices can help you bring your vision to life.